Sesti, Giorgio
 Distribuzione geografica
Continente #
NA - Nord America 13.526
EU - Europa 2.885
AS - Asia 1.751
AF - Africa 58
SA - Sud America 27
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 1
Totale 18.258
Nazione #
US - Stati Uniti d'America 13.313
IT - Italia 1.424
SG - Singapore 768
IN - India 656
SE - Svezia 396
IE - Irlanda 287
CA - Canada 190
RU - Federazione Russa 180
CN - Cina 157
DE - Germania 143
ID - Indonesia 100
UA - Ucraina 82
GB - Regno Unito 79
FI - Finlandia 75
RO - Romania 56
BG - Bulgaria 39
NL - Olanda 37
TG - Togo 34
FR - Francia 22
CH - Svizzera 21
MX - Messico 21
HK - Hong Kong 19
AR - Argentina 12
AU - Australia 10
BE - Belgio 9
IR - Iran 9
ZA - Sudafrica 8
TW - Taiwan 7
IL - Israele 6
PE - Perù 6
SC - Seychelles 6
BR - Brasile 5
TR - Turchia 5
CL - Cile 4
CZ - Repubblica Ceca 4
HU - Ungheria 4
MT - Malta 4
AT - Austria 3
ET - Etiopia 3
GR - Grecia 3
KR - Corea 3
LV - Lettonia 3
MY - Malesia 3
NO - Norvegia 3
PK - Pakistan 3
PL - Polonia 3
TZ - Tanzania 3
UZ - Uzbekistan 3
VN - Vietnam 3
CU - Cuba 2
ES - Italia 2
JO - Giordania 2
JP - Giappone 2
TN - Tunisia 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
BF - Burkina Faso 1
DK - Danimarca 1
EG - Egitto 1
EU - Europa 1
LT - Lituania 1
PH - Filippine 1
PT - Portogallo 1
QA - Qatar 1
RS - Serbia 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
Totale 18.258
Città #
Fairfield 2.769
Ashburn 1.410
Seattle 1.397
Woodbridge 1.377
Houston 1.073
Cambridge 1.033
Wilmington 893
San Paolo di Civitate 638
Singapore 426
Princeton 367
Ann Arbor 358
Millbury 351
Lawrence 347
Chandler 284
Dublin 277
San Diego 175
Rome 169
Ottawa 138
Santa Clara 120
Jakarta 96
Le Casine-Perignano-Spinelli 91
Moscow 81
Andover 76
Norwalk 70
Beijing 67
New York 65
Milan 56
Boston 54
Toronto 50
Des Moines 49
Sofia 39
Boardman 35
Plano 35
Lomé 34
Bühl 30
London 26
Helsinki 23
Lappeenranta 23
Mannheim 23
Taranto 21
Falkenstein 19
Turin 19
Mexico City 18
Stockholm 18
Bremen 17
Groningen 16
Hong Kong 16
Jacksonville 16
Dearborn 15
Phoenix 15
Falls Church 14
Bologna 13
Grafing 12
Épalinges 11
Federal 10
Naples 10
Bari 9
Hebei 9
Deiva Marina 8
Florence 8
Guangzhou 8
San Mateo 8
Springfield 8
Bern 7
Cervere 7
Fidenza 7
Fort Worth 7
Muizenberg 7
Palermo 7
Pisa 7
Provo 7
Verona 7
Frankfurt am Main 6
Mahé 6
Nanjing 6
Nuremberg 6
Prineville 6
Brussels 5
Buffalo 5
Hyderabad 5
Kilburn 5
Los Angeles 5
Pune 5
Rovigo 5
Salerno 5
Southend 5
Bergamo 4
Brno 4
Bruino 4
Budapest 4
Foligno 4
Fremont 4
Guidonia Montecelio 4
Hounslow 4
Islington 4
Kochi 4
Laurel 4
New Delhi 4
Reggio Emilia 4
Sacramento 4
Totale 15.137
Nome #
Effects on the incidence of cardiovascular events of the addition of pioglitazone versus sulfonylureas in patients with type 2 diabetes inadequately controlled with metformin (TOSCA.IT). A randomised, multicentre trial 149
Prescription appropriateness of anti-diabetes drugs in elderly patients hospitalized in a clinical setting. evidence from the REPOSI register 130
Booster dose of SARS-CoV-2 mRNA vaccines strengthens the specific immune response of patients with rheumatoid arthritis: a prospective multicenter longitudinal study 123
Rationale and design of the DARWIN-T2D (DApagliflozin real world evIdeNce in Type 2 Diabetes). A multicenter retrospective nationwide Italian study and crowdsourcing opportunity 113
IRS1 G972R polymorphism and type 2 diabetes. a paradigm for the difficult ascertainment of the contribution to disease susceptibility of ‘low-frequency–low-risk’ variants 107
TRIB3 r84 variant is associated with impaired insulin-mediated nitric oxide production in human endothelial cells 88
Glutamine to arginine substitution at amino acid 84 of mammalian tribbles homolog TRIB3 and ckd in whites with type 2 diabetes 86
Pharmacogenetics of oral antidiabetes drugs: Evidence for diverse signals at the IRS1 locus 84
null 84
Impact of lowering the criterion for impaired fasting glucose on identification of individuals with insulin resistance. The GISIR database 84
GRB10 gene and type 2 diabetes in whites 83
Infrequent TRIB3 coding variants and coronary artery disease in type 2 diabetes 83
Using INTERCheck® to Evaluate the Incidence of Adverse Events and Drug–Drug Interactions in Out- and Inpatients Exposed to Polypharmacy 83
Angiotensin (1-7) counteracts the negative effect of angiotensin II on insulin signalling in HUVECs 82
One-hour post-load hyperglycemia combined with HbA1c identifies pre-diabetic individuals with a higher cardio-metabolic risk burden 81
Pathogenic variants of MODY-genes in adult patients with early-onset type 2 diabetes 78
Guidelines for the screening and diagnosis of gestational diabetes in Italy from 2010 to 2019: critical issues and the potential for improvement 75
Frequency of 1-h post-load glucose ≥155 mg/dl among individuals with different glucose tolerance conditions 75
A fasting insulin–raising allele at IGF1 locus is associated with circulating levels of IGF-1 and insulin sensitivity. 74
TRIB3 R84 variant affects glucose homeostasis by altering the interplay between insulin sensitivity and secretion 73
Additive effect of non-alcoholic fatty liver disease on metabolic syndrome-related endothelial dysfunction in hypertensive patients 73
Role of PC-1 and ACE genes on insulin resistance and cardiac mass in never treated hypertensive patients: suggestive evidence for a digenic additive modulation 72
Comparative Impact of hypoglycemic agents on severity and extent of myocardial ischemia in patients with type 2 Diabetes mellitus undergoing myocardial perfusion scintigraphy 72
The use of real time continuous glucose monitoring or flash glucose monitoring in the management of diabetes. a consensus view of Italian diabetes experts using the Delphi method 72
Components of the metabolic syndrome and carotid atherosclerosis role of elevated blood pressure 72
Characterization of left ventricular mass in individuals at risk for type 2 diabetes identified by HbA1c levels according to the American Diabetes Association Criteria 72
Creatinine and insulin predict cardiac mass in drug-naïve hypertensive patients. 72
A Phase 2, randomized, dose-finding study of the novel once-weekly human GLP-1 analog, semaglutide, compared with placebo and open-label liraglutide in patients with type 2 diabetes 71
Association of LDL cholesterol with carotid atherosclerosis in menopausal women affected by the metabolic syndrome 71
A functional variant of the dimethylarginine dimethylaminohydrolase-2 gene is associated with insulin sensitivity 71
Comparison of Computerized Prescription Support Systems in COVID-19 Patients. INTERCheck and Drug-PIN 71
Elevated hemoglobin glycation index identify non-diabetic individuals at increased risk of kidney dysfunction 70
A common polymorphism in the promoter of UCP2 contributes to the variation in insulin secretion in glucose-tolerant subjects 70
Joint Effect of Insulin Signaling Genes on Insulin Secretion and Glucose Homeostasis 69
Association between a genetic variant related to glutamic acid metabolism and coronary heart disease in individuals with type 2 diabetes. 69
Endothelial Dysfunction and Subsequent Decline in Glomerular Filtration Rate in Hypertensive Patients 69
Ten years of experience with DPP-4 inhibitors for the treatment of type 2 diabetes mellitus 69
Higher serum levels of uric acid are associated with a reduced insulin clearance in non-diabetic individuals 69
Heart rate affects endothelial function in essential hypertension 69
Immune checkpoints inhibitors and hyperglycemia. A Meta-analysis of randomized controlled trials 69
Sympathovagal balance and 1-h postload plasma glucose in normoglucose tolerant hypertensive patients 68
ALTERED PATTERN OF INSULIN-RECEPTOR ISOTYPES IN SKELETAL-MUSCLE MEMBRANES OF TYPE-2 (NON-INSULIN-DEPENDENT) DIABETIC SUBJECTS 68
A candidate type 2 diabetes polymorphism near the HHEX locus affects acute glucose-stimulated insulin release in European populations: results from the EUGENE2 study 68
Antibodies directed to the insulin receptor. Clinical aspects and applications to the study of insulin action 68
Psychological Distress in Patients with Autoimmune Arthritis during the COVID-19 Induced Lockdown in Italy 68
Angiotensin II type 1 receptor, but no type 2 receptor, interferes with the insulin-induced nitric oxide production in HUVECs 67
3'-UTR OLR1/LOX-1 gene polymorphism and endothelial dysfunction: molecular and vascular data in never-treated hypertensive patients 67
Serum IgG2 levels are specifically associated with whole-body insulin-mediated glucose disposal in non-diabetic offspring of type 2 diabetic individuals. a cross-sectional study 67
Obese patients with a binge eating disorder have an unfavorable metabolic and inflammatory profile 67
Multiplicative effect of serum phosphorus levels and insulin resistance on hypertensive vascular stiffness 67
Impact of common polymorphisms in candidate genes for insulin resistance and obesity on weight loss of morbidly obese subjects after laparoscopic adjustable gastric banding and hypocaloric diet 67
Altered Insulin Receptor Signalling and β-Cell Cycle Dynamics in Type 2 Diabetes Mellitus 66
Angiotensin II impairs the insulin signaling pathway promoting production of nitric oxide by inducing phosphorylation of insulin receptor substrate-1 on Ser(312) and Ser(616) in human umbilical vein endothelial cells 66
Elevated Concentrations of Liver Enzymes and Ferritin Identify a New Phenotype of Insulin Resistance: Effect of Weight Loss After Gastric Banding 66
Microvascular effects of glucagon-like peptide-1 receptor agonists in type 2 diabetes. a meta-analysis of randomized controlled trials 66
A functional variant of the dimethylarginine dimethylaminohydrolase-2 gene is associated with chronic kidney disease 66
null 66
Branched-chain amino acid database integrated in MEDIPAD software as a tool for nutritional investigation of mediterranean populations 65
Efficacy and safety of dapagliflozin, a sodium glucose cotransporter 2 (SGLT2) inhibitor, in diabetes mellitus 65
Elevated 1-h post-load plasma glucose is associated with right ventricular morphofunctional parameters in hypertensive patients 65
A polymorphism at IGF1 locus is associated with carotid intima media thickness and endothelium-dependent vasodilatation. 65
Glucagon-like peptide-1 receptor agonists and atrial fibrillation. a systematic review and meta-analysis of randomised controlled trials 65
The TRIB3 Q84R polymorphism and risk of early-onset type 2 diabetes 65
A functional variant of the dimethylarginine dimethylaminohydrolase-2 gene is associated with myocardial infarction in type 2 diabetic patients 64
Plasma kisspeptin levels are associated with insulin secretion in nondiabetic individuals 64
Recurrent COVID-19 pneumonia in the course of chemotherapy: consequence of a weakened immune system? 64
The SH2B1 obesity locus is associated with myocardial infarction in diabetic patients and with NO synthase activity in endothelial cells 63
Fine-scale haplotype mapping of MUT, AACS, SLC6A15 and PRKCA genes indicates association with insulin resistance of metabolic syndrome and relationship with branched chain amino acid metabolism or regulation 63
Insulin Secretion in Metabolically Obese, but Normal Weight, and in Metabolically Healthy but Obese Individuals 63
Insulin-dependent activation of endothelial nitric oxide synthase is impaired by O-linked glycosylation modification of signaling proteins in human coronary endothelial cells 63
The common SLC30A8 Arg325Trp variant is associated with reduced first phase insulin release in 846 non-diabetic offspring of type 2 diabetes patients-the EUGENE2 study 63
Are circulating Mg2+ levels associated with glucose tolerance profiles and incident type 2 diabetes? 63
The Mammalian Tribbles Homolog TRIB3, Glucose Homeostasis, and Cardiovascular Diseases 62
The type 2 diabetes and insulin-resistance locus near IRS1 is a determinant of HDL cholesterol and triglycerides levels among diabetic subjects 62
Elevated 1-h post-challenge plasma glucose levels in subjects with normal glucose tolerance or impaired glucose tolerance are associated with whole blood viscosity 62
Metabolic syndrome. Diagnosis and clinical management, an official document of the Working Group of the Italian Society of Cardiovascular Prevention (SIPREC) 62
Endothelial dysfunction predicts regression of hypertensive cardiac mass 62
Dietary patterns and 1-h post-load glucose in essential hypertension 62
Association between one-hour post-load plasma glucose levels and vascular stiffness in essential hypertension 62
Cytokine release syndrome in COVID-19 patients, a new scenario for an old concern. The fragile balance between infections and autoimmunity 62
The Gly972 → Arg IRS-1 variant is associated with type 1 diabetes in continental Italy 61
Change in HbA1c Across the Baseline HbA1c Range in Type 2 Diabetes Patients Receiving Once-Weekly Dulaglutide Versus Other Incretin Agents 61
PHLPP phosphatases as a therapeutic target in insulin resistance-related diseases 61
The polymorphism rs35767 at IGF1 locus is associated with serum urate levels 61
Use and effectiveness of dapagliflozin in routine clinical practice. An Italian multicenter retrospective study 61
Ketogenic diet-induced weight loss is associated with an increase in vitamin d levels in obese adults 61
Increased levels of the Akt-specific phosphatase PH domain leucine-rich repeat protein phosphatase (PHLPP)-1 in obese participants are associated with insulin resistance 61
The SH2B1 obesity locus and abnormal glucose homeostasis: Lack of evidence for association from a meta-analysis in individuals of European ancestry 60
The TRIB3 R84 variant is associated with increased carotid intima media thickness in vivo and with enhanced MAPK signalling in human endothelial cells. 60
Decreased insulin clearance in individuals with elevated 1-h post-load plasma glucose levels 60
Potential role of insulin receptor isoforms and IGF receptors in plaque instability of human and experimental atherosclerosis 60
One-hour post-load hyperglycemia combined with HbA1c identifies individuals with higher risk of cardiovascular diseases. Cross-sectional data from the CATAMERI study 60
Insulin-resistance HCV infection-related affects vascular stiffness in normotensives 60
Safety issues with glucagon-like peptide-1 receptor agonists (pancreatitis, pancreatic cancer and cholelithiasis). data from randomized controlled trials 60
Metabolic and cognitive effects of ranolazine in type 2 diabetes mellitus. data from an in vivo model 60
Insulin-like growth factor-1 is a negative modulator of glucagon secretion 59
The GLP-1 receptor agonists exenatide and liraglutide activate glucose transport by an AMPK-dependent mechanism 59
Association between noninvasive fibrosis markers and cardio-vascular organ damage among adults with hepatic steatosis 59
Hyperglycemia at admission, comorbidities, and in-hospital mortality in elderly patients hospitalized in internal medicine wards: data from the RePoSI registry 59
Tissue-specific expression of two alternatively spliced isoforms of the human insulin receptor protein 58
Totale 7.042
Categoria #
all - tutte 65.691
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 65.691


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20204.230 0 0 0 0 0 0 1.020 1.001 1.010 535 501 163
2020/20211.867 155 330 155 102 84 97 79 175 326 158 136 70
2021/20223.590 57 235 423 89 440 52 120 526 177 226 731 514
2022/20232.822 602 1.076 78 184 136 171 23 92 184 76 176 24
2023/20241.898 258 148 186 92 126 154 63 100 24 380 158 209
2024/20251.173 120 95 208 214 179 326 31 0 0 0 0 0
Totale 19.644